Clinical trial
A Prospective, Open Label, Multi-center Trial of Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s) by Optical Coherent Tomography (OCT) and Coronary Angiography
NCT03040934 is registered in ClinicalTrials.gov with Shanghai MicroPort Medical (Group) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open Label, Multi-center Trial of Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s) by Optical Coherent Tomography (OCT) and Coronary Angiography
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 10, 2017
- Completion date
- October 31, 2023
- Enrollment
- 196 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-eluting stents, percutaneous coronary intervention, tomography, optical coherence